A study with Citrobacter rodentium, a murine model for pathogenic E. coli infection, showed the beneficial effect of IL4 treatments for mucosal healing by affecting mucus production, pathogen adhesion, and colitis [77]. The gene discussed is IL4; the disease is colitis.